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Abstract. We screened for malaria in 594 blood samples from febrile patients who tested negative by a Plasmodium
falciparum-specific histidine-rich protein-2-based rapid diagnostic test at 12 health facilities in Zanzibar districts North A
and Micheweni, from May to August 2010. Screening was with microscopy, polymerase chain reaction (PCR) targeting
the cytochrome b gene (cytbPCR) of the four major human malaria species, and quantitative PCR (qPCR). The
prevalence of cytbPCR-detectable malaria infection was 2% (12 of 594), including 8 P. falciparum, 3 Plasmodium
malariae, and 1 Plasmodium vivax infections. Microscopy identified 4 of 8 P. falciparum infections. Parasite density as
estimated by microscopy or qPCR was > 4,000 parasites/mL in 5 of 8 cytbPCR-detectable P. falciparum infections. The
infections that were missed by the rapid diagnostic test represent a particular challenge in malaria elimination settings
and highlight the need for more sensitive point-of-care diagnostic tools to improve case detection of all human malaria
species in febrile patients.
Zanzibar has been the site of a substantial recent effort to
reduce the overall burden of malaria. With these efforts, the
prevalence of parasitologically confirmed malaria infection
among febrile children presenting at primary health care facil-
ities in Zanzibar has decreased from ~25% in 20031 to 2% in
2010 (Shakely and others, unpublished data). Historically,
Plasmodium falciparum has played a dominant role in malar-
ial illness in Zanzibar, and elsewhere in sub-Saharan Africa,
causing well over 90% of episodes of the disease2,3; the
remaining reported malaria infections in Zanzibar in recent
years have been caused by Plasmodium malariae.2
Malaria rapid diagnostic tests (RDTs) that detect parasite
antigens have improved the availability of parasite-based
diagnosis for rural clinics in Africa.4 However, the RDT cur-
rently used in most of sub-Saharan Africa and in Zanzibar at
the time of this study detects histidine-rich protein-2 (HRP2),
which is specific to P. falciparum, and does not detect other
species of malaria parasites.5
The availability of highly sensitive molecular techniques pro-
vides an opportunity to better characterize the species of
Plasmodia causing malaria in regions of sub-Saharan Africa
experiencing decreasing P. falciparum transmission. The aim of
this study was to assess the prevalence of polymerase chain reac-
tion (PCR)-detectable malaria infection among febrile patients
with a negativeP. falciparum-specific RDT in Zanzibar.
Samples for this study were from an RDT effectiveness trial
(Shakely andothers, unpublisheddata) performed in 12Zanzibar
primary health care facilities, six each inNorthA andMicheweni
districts over a 12-week period during the high transmis-
sion season from May to August 2010. Inclusion criteria in this
study were: age ³ 2 months, a measured axillary temperature
³ 37.5°C or history of fever in the preceding 24 hours, and
absence of any danger signs of severe disease.6
After obtaining informed written consent, dried blood spots
were collected from febrile patients who tested negative for
malaria by an HRP2-based RDT (Paracheck Pf) and a short
questionnaire was administered to gather demographic infor-
mation and travel histories. Travel was defined as having spent
at least one night away from the home in the past 30 days,
either within Zanzibar or abroad. For children < 15 years of
age, consent and questionnaire were administered to the
accompanying adult. Five hundred ninety-four participants
who tested negative by RDT at enrollment were randomly
selected for additional blood sampling by microscopy and
PCR and are included in this analysis.
Trained health facility personnel performed specimen col-
lection and interpreted RDT results. In 10 out of 12 study
sites, RDT use is part of the routine management of febrile
illness, whereas in the remaining two sites, microscopy is the
standard diagnostic method. Following confirmation of a neg-
ative RDT result and informed consent, blood from a finger
prick was collected onto a blood slide and a filter paper
(Whatman 3MM, Florham Park, NJ), which were labeled with
unique identifiers. Filter paper samples were dried overnight
and stored in sealed bags at ambient temperature with desic-
cant. Before the start of the study, district supervisors and clinic
health care personnel were trained in Integrated Management
of Childhood Illness (IMCI),6 standardized blood sample col-
lection, sample storage, and questionnaire data collection.
A two-stage PCR-based pooling strategy, as previously
described,7 was used to characterize samples. Briefly, DNA
was extracted from sets of 10 pooled samples, and subsequently
from all individual samples in pools testing positive. At each
stage, a nested PCR reaction using primers common to the
cytochrome b genes of the four major human malaria species,8
followed by anAluI restriction digest to distinguish species, was
performed (cytbPCR).9 Duplex quantitative PCR targeting the
human b tubulin gene and the plasmodial methionine transfer
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RNA (tRNA) gene (pgmet) was performed to quantify parasite
density relative to human DNA, as previously described.10 To
obtain estimates of parasite density, a standard curve was
derived from filter paper controls created using known densities
of cultured parasites serially diluted in whole blood from three
donors. We have found this method to reliably detect and quan-
tify concentrations of 25 parasites/mL or higher from filter paper
samples (Hsiang and others, unpublished data). Microscopic
investigations of Giemsa-stained thick blood smears were per-
formed according to standard practice for malaria diagnosis11;
asexual parasite densities were calculated against 200 white
blood cells, assuming 8,000 white blood cells per microliter of
blood. Blood slides were recorded as negative if no parasites
were found after examining 100 high power microscopy fields.
All blood slides were examined by two qualified laboratory
technicians in Zanzibar. Differences in species identification
or parasite density of > 50% were subjected to a third decisive
examination by an independent expert microscopist.
All data were entered in Excel (Microsoft Corp., Redmond,
WA), converted to comma-separated text and imported into
SAS Version 9.2 (SAS Institute Inc., Cary, NC). Data were
cleaned in SAS to check for duplications and identify any
missing or discrepant data. Fisher’s exact test was used to
compare categorical demographic variables and PCR results.
This study was approved by the Zanzibar Medical Research
Ethical Committee (ZAMREC), the University of California
San Francisco Committee for Human Research (CHR), and
the Regional Ethics Committee Stockholm, Sweden.
A total of 594 RDT negative subjects were enrolled: 270
from North A district and 324 from Micheweni district.
Demographic data and travel history of the study participants
are presented in Table 1. Overall, 12 of 594 (2%) RDT-negative
samples were positive by cytbPCR, including 8 P. falciparum,
3 P. malariae, and 1 Plasmodium vivax infections (Table 2). No
multi-species infections were identified by cytbPCR. Micros-
copy was positive for 4 of 8 P. falciparum infections, with
parasite densities ranging from 4,309 to 43,886 parasites/mL,
but for only 1 of 4 of the cytbPCR-detectable non-falciparum
infections. The latter infection, which was identified as
P. malariae by cytbPCR, had a very low density, i.e., insuffi-
cient to allow species identification, by microscopy. Similarly,
qPCR verified parasitemia in 4 of 8 of the ctybPCR-detectable
P. falciparum infections, with parasite densities estimated
from 3,057 to 13,516 parasites/mL. However, none of the non-
falciparum infections identified by cytbPCR had detectable
parasitemia by qPCR. There were no statistically significant
differences in sex, age, or travel history between cytbPCR neg-
ative and positive subjects. Of note, none of the cytbPCR-
detectable non-falciparum infections occurred in subjects that
reported travel, suggesting the infections were acquired locally
(Table 2).
The prevalence of PCR-detectable malaria infection among
febrile patients with a negative P. falciparum-specific RDT in
Zanzibar was low. A majority of these infections were caused
by P. falciparum. Of importance, only half of the cytbPCR-
detectable P. falciparum infections, and only one of the non-
falciparum infections, were identified by microscopy. The
presence of PCR-detectable non-falciparum and P. falciparum
infections that were missed by the HRP-2-based RDT iden-
tifies a particular challenge in a malaria pre-elimination setting
like Zanzibar, because such infections are unlikely to be
detected by the presently available point-of-care malaria
diagnostic tools.12 Some false-negative RDT results might be
explained by infection with P. falciparumwith altered to absent
HRP2, although this possibility requires additional study
involving extensive sequencing and consideration of multiple
PCR and sequencing primers to account for known sequence
variability.13–16 Additionally, although our health facility per-
sonnel were trained in the collection of specimens for RDTs, it
is possible that human error in test performance may explain
some of the false-negative RDT results. In any event, our
results suggest the need in malaria elimination settings for
development of more sensitive point-of-care diagnostic tools
to ensure improved case detection of all major human malaria
species in febrile patients.
Received February 10, 2012. Accepted for publication October 1, 2012.
Published online December 18, 2012.
Acknowledgments: We thank the district supervisors and health facil-
ity workers in Zanzibar, namely Districts North A andMicheweni, for
their contributions to the study data collection. We also thank the
clinic patients and their caregivers who made this study possible.
Financial support: This study was funded by the ACT Consortium
through an award from the Bill and Melinda Gates Foundation to the
Table 1
Selected characteristics among enrolled patients with a negative
malaria rapid diagnostic test, Zanzibar districts North A and
Micheweni (N = 594)
Variable n (%)
cytbPCR positive cytbPCR negative
P valuen (%) n (%)
Sex
Male 245 (41) 6 (2) 239 (98) 0.57
Female 343 (58) 6 (2) 337 (98)
Missing data 6 (1)
Total 594
Age
£ 18 years 360 (61) 4 (1) 356 (99) 0.07
> 18 years 228 (38) 8 (4) 220 (96)
Missing data 6 (1)
Total 594
Travel*
Yes 72 (12) 1 (1) 71 (99) 1.000
No 522 (88) 11 (2) 511 (98)
Total 594
*Having spent at least one night away from home in the past 30 days, either within
Zanzibar or abroad.
Table 2
Features of infections with a negative malaria rapid diagnostic test







P. falciparum 33 male no 4,309 4,714
P. falciparum 20 male no 14,420 3,057
P. falciparum 5 male yes 21,991 report unavailable
P. falciparum 8 female no 43,886 8,018
P. falciparum 24 female no negative negative
P. falciparum 35 male no negative negative
P. falciparum 1 female no negative negative
P. falciparum 24 female no negative 13,516
P. malariae 29 male no 10* 1.48
P. malariae 30 female no negative negative
P. malariae 25 male no negative negative
P. vivax 4 female no negative negative
*This low parasite density did not allow for species identification.
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